Intuitive Surgical
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Intuitive Surgical sits in the top decile of US sponsors by registered trial count (#434 of 15,742 sponsors by registered trial count).
Intuitive Surgical: 40 sponsored US clinical trials, 3 recruiting.
Intuitive Surgical sponsors 40 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 28 completed. 1 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Lung Cancer, with 3 trials.
Top-decile sponsor footprint
Intuitive Surgical ranks in the top decile of sponsors by registered trial count (#434 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
28 of 29 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
40 total, page 1 of 1
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
NCT06879912
Retrospective Acute Care Appendectomy Study
NCT06624215
Real World Registry for Use of the Ion Endoluminal System
NCT06004440
Robotic vs. Open NSM for Early Stage Breast Cancer
NCT05720039
Clinical Investigation of the da Vinci Surgical System
NCT05682742
SP Thoracic IDE Study
NCT05150210
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
NCT04403022
Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy
NCT03892980
Open Nipple Sparing Mastectomy (NSM)
NCT04447339
Early Surgeon Experience With Robotic-Assisted Inguinal Hernia Repair
NCT04353687
Clinical Utility for Ion Endoluminal System
NCT03893539
Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures.
NCT06434727
IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery
NCT05954767
IS-002 Phase 2 Prostate Cancer Study
NCT05946603
A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery
NCT05769257
A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy
NCT05562895
A Multicenter Retrospective Review to Evaluate the Feasibility of Dye Marking Using the Ion Endoluminal System
NCT05546437
Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch Bariatric Surgical Procedures
NCT05575947
A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions
NCT05160571
A Prospective Evaluation of Pain After Non-complex Ventral Hernia Repair
NCT04855227
Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy
NCT04888117
Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence
NCT04735341
Prospective Robotic-assisted Revisional Bariatric Study
NCT04506190
A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy
NCT04574401
A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy
NCT04329767
Study of Peri-operative and Acute Outcomes After Robotic-assisted Cholecystectomy
NCT04551820
Pain and Quality of Life After Retromuscular Ventral Hernia Repair (RECOVER)
NCT04487522
Retrospective Comparison of Lap and Robotic-Assisted RYGB and SG
NCT04329780
A Prospective Single-Center Evaluation of SureForm™ Staplers in Robotic-assisted Colorectal Procedures
NCT04247958
Pain and Quality of Life After Inguinal Hernia Repair
NCT04074200
A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy
NCT03937505
Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses
NCT03312569
Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer
NCT03347825
Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study
NCT03049280
IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics
NCT03006237
A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients
NCT02715622
Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
NCT02684448
Robotic-assisted Versus Laparoscopic Sigmoid Resection
NCT02636673
A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures
NCT02002845
Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy
NCT01932216
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the Intuitive Surgical pipeline
3 recruiting of 40 indexed (8% open); 28 completed (70%).
Phase mix: 1 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Lung Cancer (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Intuitive Surgical: open-pipeline peers nationwide
Peers matched on 40 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Intuitive Surgical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 40 trials (± recruiting share)
- Baptist Health South Florida · 40 trials · 43% recruiting
- BTL Industries · 40 trials · 8% recruiting
- Celgene Corporation · 40 trials · 0% recruiting
- Harvard School of Public Health (HSPH) · 40 trials · 3% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Louisiana State University Health Sciences Center Shreveport · 8% recruiting · 40 trials
- University of Kansas · 8% recruiting · 66 trials
- Akron Children's Hospital · 7% recruiting · 27 trials
- AVEO Pharmaceuticals · 7% recruiting · 27 trials
Related
What to do with this Intuitive Surgical page
40 registered trials is a research-attention snapshot, not an endorsement of Intuitive Surgical or any single study.
- 3 of Intuitive Surgical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lung Cancer is the condition Intuitive Surgical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lung Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Intuitive Surgical pipeline card: 40 registered trials from official public datasets.Report a data error.